Cargando…

Endothelial dysfunction in patients with ankylosing spondylitis

Ankylosing spondylitis (AS) is associated with accelerated atherosclerosis and enhanced cardiovascular morbidity and mortality compared to the general population. The mechanisms and mediators of this phenomenon have not been fully explained, but an expanding body of evidence demonstrates that increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Łosińska, Katarzyna, Korkosz, Mariusz, Kwaśny-Krochin, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2019
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532117/ https://www.ncbi.nlm.nih.gov/pubmed/31130748 http://dx.doi.org/10.5114/reum.2019.84815

Ejemplares similares

Assessing Endothelial Dysfunction in Patients with Ankylosing Spondylitis
por: TUDORAȘCU, D.R., et al.
Publicado: (2016)

Vitamin D serum concentration is not related to the activity of spondyloarthritis – preliminary study
por: Guła, Zofia, et al.
Publicado: (2018)

Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
por: Klimek, Ewa, et al.
Publicado: (2014)

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
por: Guła, Zofia, et al.
Publicado: (2017)

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023)

Low vaspin levels are related to endothelial dysfunction in patients with ankylosing spondylitis
por: Wang, H.H., et al.
Publicado: (2016)

Erectile dysfunction in ankylosing spondylitis patients
por: Santana, Thiago, et al.
Publicado: (2017)

Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic
por: Łosińska, Katarzyna, et al.
Publicado: (2022)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis
por: Brkic, Alen, et al.
Publicado: (2022)

Adipokines, Biomarkers of Endothelial Activation, and Metabolic Syndrome in Patients with Ankylosing Spondylitis
por: Genre, Fernanda, et al.
Publicado: (2014)

High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage
por: Korkosz, Mariusz, et al.
Publicado: (2013)

Blood Monocyte Subsets and Selected Cardiovascular Risk Markers in Rheumatoid Arthritis of Short Duration in relation to Disease Activity
por: Klimek, Ewa, et al.
Publicado: (2014)

Update on the treatment of ankylosing spondylitis
por: Maksymowych, Walter P
Publicado: (2007)

Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007)

Microbes, the gut and ankylosing spondylitis
por: Costello, Mary-Ellen, et al.
Publicado: (2013)

Cardiac Involvement in Ankylosing Spondylitis
por: Ozkan, Yasemin
Publicado: (2016)

Management of ankylosing spondylitis with infliximab
por: Toussirot, Éric, et al.
Publicado: (2009)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Erectile dysfunction in ankylosing spondylitis: a systematic review and meta-analysis
por: Zhang, Yuyang, et al.
Publicado: (2023)

Cardiopulmonary Manifestations of Ankylosing Spondylitis
por: Momeni, Mahnaz, et al.
Publicado: (2011)

Advances in managing ankylosing spondylitis
por: Daikh, David I., et al.
Publicado: (2014)

Medical Treatment of Ankylosing Spondylitis
por: Moon, Kyoung-Ho, et al.
Publicado: (2014)

Autophagy dysfunction may be involved in the pathogenesis of ankylosing spondylitis
por: Tan, Min, et al.
Publicado: (2020)

Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis
por: Talotta, Rossella, et al.
Publicado: (2020)

Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT) - 10-year follow-up
por: Korkosz, Mariusz, et al.
Publicado: (2011)

Advances in nanomedicine for the treatment of ankylosing spondylitis
por: Xi, Yanhai, et al.
Publicado: (2019)

Treatment of ankylosing spondylitis: focus on etanercept
por: Frech, Tracy
Publicado: (2007)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

Efficacy and safety of adalimumab in ankylosing spondylitis
por: Mounach, Aziza, et al.
Publicado: (2014)

Intestinal Microbial Metabolites in Ankylosing Spondylitis
por: Scalise, Giuseppe, et al.
Publicado: (2021)

Investigation of Cardiac Complications and their Incidence in Patients with Ankylosing Spondylitis
por: Soroush, Mohsen, et al.
Publicado: (2016)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

An Epidemiological Study on Ankylosing Spondylitis in Southern Albania
por: Koko, Vjollca, et al.
Publicado: (2014)

New developments in ankylosing spondylitis—status in 2021
por: Klavdianou, Kalliopi, et al.
Publicado: (2021)

Chromosomal Distribution of Ankylosing Spondylitis Susceptibility Loci
por: Saadat, Mostafa
Publicado: (2023)

Ankylosing spondylitis: etiology, pathogenesis, and treatments
por: Zhu, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6p8prhaaukf4hgv52bl9tol448